Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons

Diabetes
Jessica M AdamsDavid P Olson

Abstract

Glucagon-like peptide 1 receptor (GLP-1R) agonists are U.S. Food and Drug Administration-approved weight loss drugs. Despite their widespread use, the sites of action through which GLP-1R agonists (GLP1RAs) affect appetite and body weight are still not fully understood. We determined whether GLP-1Rs in either GABAergic or glutamatergic neurons are necessary for the short- and long-term effects of the GLP1RA liraglutide on food intake, visceral illness, body weight, and neural network activation. We found that mice lacking GLP-1Rs in vGAT-expressing GABAergic neurons responded identically to controls in all parameters measured, whereas deletion of GLP-1Rs in vGlut2-expressing glutamatergic neurons eliminated liraglutide-induced weight loss and visceral illness and severely attenuated its effects on feeding. Concomitantly, deletion of GLP-1Rs from glutamatergic neurons completely abolished the neural network activation observed after liraglutide administration. We conclude that liraglutide activates a dispersed but discrete neural network to mediate its physiological effects and that these effects require GLP-1R expression on glutamatergic but not GABAergic neurons.

References

Jun 9, 2005·Physiology & Behavior·Yong-Ling LiuPaul L R Andrews
Oct 12, 2007·Physiological Reviews·Jens Juul Holst
Dec 15, 2007·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Christopher J PriceAlastair V Ferguson
Feb 7, 2008·The Journal of Pharmacology and Experimental Therapeutics·William J ThomsenDominic Behan
Sep 10, 2008·Canadian Journal of Experimental Psychology = Revue Canadienne De Psychologie Expérimentale·Linda A ParkerCheryl L Limebeer
Dec 17, 2008·Endocrinology·Diana L WilliamsMichael W Schwartz
Jan 29, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Elena-Dana BaraboiDenis Richard
Mar 11, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jason G BarreraRandy J Seeley
Jul 22, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Elena-Dana BaraboiDenis Richard
Oct 14, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Amanda M DossatDiana L Williams
Sep 5, 2012·Nature Reviews. Endocrinology·Juris J Meier
Jan 23, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J A ParkerS R Bloom
Sep 4, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J van CanW H M Saris
Dec 11, 2013·The Journal of Endocrinology·L van BloemendaalM Diamant
Feb 4, 2014·Nature·Michael J KrashesBradford B Lowell
Apr 1, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Amber L AlhadeffHarvey J Grill
Apr 26, 2014·The Journal of Clinical Investigation·Stephanie SisleyRandy J Seeley
Sep 10, 2014·The Journal of Clinical Investigation·Anna SecherLotte Bjerre Knudsen
Nov 14, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Amy K SuttonDavid P Olson
Jul 3, 2015·The New England Journal of Medicine·Xavier Pi-SunyerUNKNOWN SCALE Obesity and Prediabetes NN8022-1839 Study Group
Apr 1, 2016·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Scott E KanoskiKarolina P Skibicka
May 31, 2016·Cell·Erika K WilliamsStephen D Liberles
Jan 6, 2017·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sriparna GhosalJames P Herman
Feb 22, 2017·The Journal of Clinical Investigation·Ronald P GaykemaMichael M Scott
Aug 16, 2017·American Journal of Physiology. Endocrinology and Metabolism·Melissa A BurmeisterJulio E Ayala

❮ Previous
Next ❯

Citations

Jun 13, 2019·Scientific Reports·Claudia G LiberiniMatthew R Hayes
Jun 18, 2019·Current Diabetes Reviews·Patoulias DimitriosKaragiannis Asterios
Jun 10, 2020·Endocrinology·Harvey J Grill
Mar 15, 2020·The Journal of Comparative Neurology·Devon L GrahamGregg D Stanwood
Mar 28, 2020·JCI Insight·Sanaz GaberyWouter Frederik Johan Hogendorf
Jun 26, 2020·Metabolic Syndrome and Related Disorders·Rona ZhouArthur Swislocki
Apr 30, 2019·Frontiers in Endocrinology·Lotte Bjerre Knudsen, Jesper Lau
Nov 13, 2020·The Journal of Clinical Endocrinology and Metabolism·Milena Monfort-PiresLicio A Velloso
Dec 16, 2020·Endocrine Reviews·Brent A McLeanDaniel J Drucker
Nov 27, 2019·Molecular Metabolism·T D MüllerM H Tschöp
Dec 6, 2020·Neuron·Chuchu ZhangStephen D Liberles
Feb 3, 2021·Molecular Metabolism·Henrik H HansenJacob Hecksher-Sørensen
Feb 17, 2021·Nature Metabolism·Daniel I BrierleyStefan Trapp
Feb 18, 2021·Proceedings of the National Academy of Sciences of the United States of America·Paul V SabatiniRandy J Seeley
Mar 13, 2021·Molecular Metabolism·Kaare V GrunddalBirgitte Holst
Mar 25, 2021·Obesity·Hans-Rudolf BerthoudSusan B Roberts
Mar 27, 2021·Nature Metabolism·Mette Q LudwigTune H Pers
Apr 9, 2021·Frontiers in Endocrinology·Christine A MarchIngrid M Libman
May 1, 2021·International Journal of Molecular Sciences·Hyunmi KimKyoung-Jin Oh
Aug 31, 2021·RSC Chemical Biology·Edin MuratspahićDavid J Craik
Oct 10, 2021·Molecular Metabolism·Daniel J Drucker
Sep 15, 2021·British Journal of Pharmacology·Anita KabahiziKevin W Williams

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.